News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019
News Conference News ESC 2013 Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib Yael L. Maxwell September 02, 2013